Contact

All Stories

  1. Feline morbillivirus elicits robust neutralizing antibodies in domestic cats without cross-neutralizing activities against canonical morbilliviruses

    Article • Journal of General Virology, February 2026, Society for General Microbiology

    Dr Makoto Takeda

  2. Discover the Future of Virus Vector: Introducing Photocontrollable Bovine Parainfluenza Virus Type 3

    Article • Microbiology and Immunology, January 2023, Wiley

    Dr Makoto Takeda

  3. Performance Evaluation of Real-Time RT-PCR Assays for the Detection of Severe Acute Respiratory Syndrome Coronavirus-2 Developed by the National Institute of Infectious Diseases, Japan

    Article • Japanese Journal of Infectious Diseases, September 2021, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Makoto Takeda

  4. Less frequent sequence mismatches in variants of concern (VOCs) of SARS-CoV-2 in the real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan

    Article • Japanese Journal of Infectious Diseases, June 2021, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Makoto Takeda

  5. HAI-2, a host factor that brakes the growth of SARS-CoV-2

    Article • Journal of Virology, May 2021, ASM Journals

    Dr Makoto Takeda

  6. For the Final Phase of Fight Against Polio Virus

    Article • Scientific Reports, March 2021, Springer Science + Business Media

    Dr Makoto Takeda

  7. Canine distemper virus infecting monkeys. Is it safe for humans? Why you can say so?

    Article • Molecules, February 2021, MDPI AG

    Dr Makoto Takeda, Professor Yasuteru Shigeta

  8. Computational Analysis Reveals a Critical Point Mutation in the N-Terminal Region of the Signaling Lymphocytic Activation Molecule Responsible for the Cross-Species Infection with Canine Distemper Virus

    Article • February 2021, MDPI AG

    Dr Makoto Takeda, Professor Yasuteru Shigeta

  9. An Ultra-Rapid Real-Time RT-PCR Method Using the PCR1100 to Detect Severe Acute Respiratory Syndrome Coronavirus-2

    Article • Japanese Journal of Infectious Diseases, January 2021, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Makoto Takeda

  10. Fighting SARS-CoV-2: A Rapid Effort in the Early Days of an Epidemic in Japan

    Article • Japanese Journal of Infectious Diseases, September 2020, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Makoto Takeda

  11. Recent Molecular Evolution of Human Metapneumovirus (HMPV): Subdivision of HMPV A2b Strains

    Article • Microorganisms, August 2020, MDPI AG

    Dr Makoto Takeda

  12. Measles Virus Hemagglutinin Protein Establishes a Specific Interaction With the Extreme N-Terminal Region of Human Signaling Lymphocytic Activation Molecule to Enhance Infection

    Article • Frontiers in Microbiology, August 2020, Frontiers

    Dr Makoto Takeda

  13. Rapidly developed and superior detection method for SARS-CoV-2 in Japan very early in the epidemic.

    Article • Japanese Journal of Infectious Diseases, July 2020, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Makoto Takeda

  14. Antiviral activities of mycophenolic acid and IMD‐0354 against SARS‐CoV‐2

    Article • Microbiology and Immunology, July 2020, Wiley

    Dr Makoto Takeda

  15. Phocine distemper virus uses phocine and other animal SLAMs as a receptor but not human SLAM

    Article • Microbiology and Immunology, July 2020, Wiley

    Dr Makoto Takeda

  16. Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship

    Article • The Journal of Infectious Diseases, July 2020, Oxford University Press (OUP)

    Dr Makoto Takeda

  17. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

    Article • Proceedings of the National Academy of Sciences, June 2020, Proceedings of the National Academy of Sciences

    Yoshihiro Kawaoka, Dr Makoto Takeda

  18. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner

    Article • Viruses, June 2020, MDPI AG

    Dr Makoto Takeda

  19. The species barrier of morbilliviruses may be surprisingly low

    Article • Current Opinion in Virology, April 2020, Elsevier

    Dr Makoto Takeda

  20. VeroE6/TMPRSS2 cell line for isolation of the novel coronavirus SARS-CoV-2

    Article • Proceedings of the National Academy of Sciences, March 2020, Proceedings of the National Academy of Sciences

    Dr Makoto Takeda

  21. Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells

    Article • Molecular Therapy, January 2020, Elsevier

    Dr Makoto Takeda

  22. The initial response of the laboratory diagnosis team to SARS-CoV-2 in Japan and the current situation

    Article • Proceedings for Annual Meeting of The Japanese Pharmacological Society, January 2020, Japanese Pharmacological Society

    Dr Makoto Takeda

  23. Heat Shock Protein 90 Ensures the Integrity of Rubella Virus p150 Protein and Supports Viral Replication

    Article • Journal of Virology, September 2019, ASM Journals

    Dr Makoto Takeda

  24. Why distemper virus infects dogs?

    Article • Viruses, August 2019, MDPI AG

    Dr Makoto Takeda

  25. Biophysical characterization and single‐chain Fv construction of a neutralizing antibody to measles virus

    Article • European Journal of Biochemistry, July 2019, Wiley

    Dr Makoto Takeda

  26. Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018

    Article • MMWR Morbidity and Mortality Weekly Report, July 2019, Centers for Disease Control MMWR Office

    Dr Makoto Takeda

  27. Nationwide Molecular Epidemiology of Measles Virus in Japan Between 2008 and 2017

    Article • Frontiers in Microbiology, July 2019, Frontiers

    Dr Makoto Takeda

  28. Viruses killing dolphines, whales, and seals.

    Article • Viruses, July 2019, MDPI AG

    Dr Makoto Takeda

  29. Unleashing Precision in Gene Therapy and Cancer Treatment: Photocontrollable Mononegaviruses

    Article • Proceedings of the National Academy of Sciences, May 2019, Proceedings of the National Academy of Sciences

    Dr Makoto Takeda

  30. The R2TP complex regulates paramyxovirus RNA synthesis

    Article • PLoS Pathogens, May 2019, PLOS

    Dr Makoto Takeda, Dr Hiroshi Katoh

  31. Consensus and variations in cell line specificity among human metapneumovirus strains

    Article • PLOS One, April 2019, PLOS

    Dr Makoto Takeda

  32. The Association Between Documentation of Koplik Spots and Laboratory Diagnosis of Measles and Other Rash Diseases in a National Measles Surveillance Program in Japan

    Article • Frontiers in Microbiology, February 2019, Frontiers

    Dr Makoto Takeda

  33. Critical role of TMPRSS2 for MERS and SARS pathology

    Article • Journal of Virology, January 2019, ASM Journals

    Dr Makoto Takeda

  34. Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus

    Article • Journal of Virology, January 2019, ASM Journals

    Dr Makoto Takeda

  35. Predominant Detection of the Subgroup A2b Human Metapneumovirus Strain with a 111-Nucleotide Duplication in the G gene in Yokohama City, Japan in 2018

    Article • Japanese Journal of Infectious Diseases, January 2019, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Makoto Takeda

  36. Protease-dependent virus tropism and pathogenicity: The role for TMPRSS2

    Article • Uirusu, January 2019, Japanese Association of Virology

    Dr Makoto Takeda

  37. New human metapneumovirus variatn strain

    Article • Microbiology and Immunology, November 2017, Wiley

    Dr Makoto Takeda

  38. Entry mechanism of rubella virus: Role for membrane lipids

    Article • Journal of Virology, October 2017, ASM Journals

    Dr Makoto Takeda

  39. Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins

    Article • Scientific Reports, September 2017, Nature

    Dr Makoto Takeda

  40. Molecular Epidemiology of Rubella Virus Strains Detected Around the Time of the 2012–2013 Epidemic in Japan

    Article • Frontiers in Microbiology, August 2017, Frontiers

    Dr Makoto Takeda

  41. A method for detecting rash and fever illness-associated viruses using multiplex reverse transcription polymerase chain reaction

    Article • Microbiology and Immunology, August 2017, Wiley

    Professor Hirokazu Kimura, Dr Makoto Takeda

  42. Expression of canine distemper virus receptor nectin-4 in the central nervous system of dogs

    Article • Scientific Reports, March 2017, Springer Science + Business Media

    Dr Makoto Takeda

  43. Evolution of human metapneumovirus: New variants emerged in 2014.

    Article • Frontiers in Microbiology, March 2017, Frontiers

    Dr Makoto Takeda

  44. Heat Shock Protein 90 Ensures Efficient Mumps Virus Replication by Assisting with Viral Polymerase Complex Formation

    Article • Journal of Virology, January 2017, ASM Journals

    Dr Hiroshi Katoh, Dr Makoto Takeda

  45. Measles Virus

    Article • Uirusu, January 2017, Japanese Association of Virology

    Dr Makoto Takeda

  46. Corrigendum to “Evaluation of sensitivity of TaqMan RT-PCR for rubella virus detection in clinical specimens” [J. Clin. Virol. 80 (2016) 98–101]

    Article • Journal of Clinical Virology, September 2016, Elsevier

    Dr Makoto Takeda

  47. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Dr. Zene Matsuda, Dr Makoto Takeda

  48. Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability

    Article • Viruses, August 2016, MDPI AG

    Dr Makoto Takeda

  49. Measles

    Article • Nature Reviews Disease Primers, July 2016, Nature

    Dr Makoto Takeda

  50. Difference between Flu A and Flu B viruses in their activation mechanism

    Article • Scientific Reports, July 2016, Nature

    Dr Makoto Takeda

  51. Evaluation of sensitivity of TaqMan RT-PCR for rubella virus detection in clinical specimens

    Article • Journal of Clinical Virology, July 2016, Elsevier

    Dr Makoto Takeda

  52. Chronological changes of mumps virus genotypes in Japan between 1999–2013

    Article • Infectious Diseases, May 2016, Taylor & Francis

    Dr Makoto Takeda

  53. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010–2015

    Article • MMWR Morbidity and Mortality Weekly Report, May 2016, Centers for Disease Control MMWR Office

    Dr Makoto Takeda

  54. Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen

    Article • Frontiers in Microbiology, April 2016, Frontiers

    Dr Makoto Takeda

  55. Analysis of the temperature sensitivity of Japanese rubella vaccine strain TO-336.vac and its effect on immunogenicity in the guinea pig

    Article • Virology, April 2016, Elsevier

    Dr Makoto Takeda

  56. Amino acid substitutions in the heptad repeat A and C regions of the F protein responsible for neurovirulence of measles virus Osaka-1 strain from a patient with subacute sclerosing panencephalitis

    Article • Virology, January 2016, Elsevier

    Dr Makoto Takeda

  57. A chicken homologue of nectin-4 functions as a measles virus receptor

    Article • Vaccine, January 2016, Elsevier

    Dr Makoto Takeda

  58. Non Susceptibility of Neonatal and Adult Rats against the Middle East Respiratory Syndrome Coronavirus

    Article • Japanese Journal of Infectious Diseases, January 2016, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Makoto Takeda

  59. Mumps Virus Is Released from the Apical Surface of Polarized Epithelial Cells, and the Release Is Facilitated by a Rab11-Mediated Transport System

    Article • Journal of Virology, September 2015, ASM Journals

    Dr Hiroshi Katoh, Dr Makoto Takeda

  60. Molecular evolution of haemagglutinin (H) gene in measles virus

    Article • Scientific Reports, July 2015, Nature

    Dr Makoto Takeda

  61. 5. Newly Developed Measles Virus Vector Can Simultaneously Transfer Multiple Genes Into Human Hematopoietic Cells and Induce Ground State Like Pluripotent Stem Cells

    Article • Molecular Therapy, May 2015, Elsevier

    Dr Makoto Takeda

  62. Alternative (TMPRSS2-independent) activation mechanism of influenza virus

    Article • Journal of Virology, February 2015, ASM Journals

    Dr Makoto Takeda

  63. Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection

    Article • Hepatology, January 2015, Wiley

    Dr Makoto Takeda

  64. Heat Shock Protein 70 Regulates Degradation of the Mumps Virus Phosphoprotein via the Ubiquitin-Proteasome Pathway

    Article • Journal of Virology, December 2014, ASM Journals

    Dr Hiroshi Katoh, Dr Makoto Takeda

  65. Development of an improved RT-LAMP assay for detection of currently circulating rubella viruses

    Article • Journal of Virological Methods, October 2014, Elsevier

    Dr Makoto Takeda

  66. Biased hypermutation occurred frequently in a gene inserted into the IC323 recombinant measles virus during its persistence in the brains of nude mice

    Article • Virology, August 2014, Elsevier

    Dr Makoto Takeda

  67. Short Self-Interacting N-Terminal Region of Rubella Virus Capsid Protein Is Essential for Cooperative Actions of Capsid and Nonstructural p150 Proteins

    Article • Journal of Virology, July 2014, ASM Journals

    Dr Makoto Takeda

  68. Ongoing increase in measles cases following importations, Japan, March 2014: times of challenge and opportunity

    Article • Western Pacific Surveillance and Response, May 2014, World Health Organization, Western Pacific Regional Office

    Dr Makoto Takeda

  69. Functionally Distinct Effects of the C-Terminal Regions of IKKε and TBK1 on Type I IFN Production

    Article • PLOS One, April 2014, PLOS

    Professor Hirokazu Kimura, Dr Makoto Takeda

  70. Biological Activating Enzyme of Influenza Viruses Finally Revealed

    Article • Journal of Virology, March 2014, ASM Journals

    Dr Makoto Takeda

  71. An Outbreak of Acute Respiratory Infections due to Human Respiratory Syncytial Virus in a Nursing Home for the Elderly in Ibaraki, Japan, 2014

    Article • Japanese Journal of Infectious Diseases, January 2014, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Professor Hirokazu Kimura, Dr Makoto Takeda

  72. The V Protein of Canine Distemper Virus Is Required for Virus Replication in Human Epithelial Cells

    Article • PLOS One, December 2013, PLOS

    Dr Makoto Takeda

  73. The MyD88 Pathway in Plasmacytoid and CD4+ Dendritic Cells Primarily Triggers Type I IFN Production against Measles Virus in a Mouse Infection Model

    Article • The Journal of Immunology, September 2013, The American Association of Immunologists

    Dr Makoto Takeda

  74. The Measles Virus Nucleocapsid Protein Tail Domain Is Dispensable for Viral Polymerase Recruitment and Activity

    Article • Journal of Biological Chemistry, September 2013, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Makoto Takeda

  75. TMPRSS2 Is an Activating Protease for Respiratory Parainfluenza Viruses

    Article • Journal of Virology, August 2013, ASM Journals

    Dr Makoto Takeda

  76. Measles Virus Nonstructural C Protein Modulates Viral RNA Polymerase Activity by Interacting with Host Protein SHCBP1

    Article • Journal of Virology, June 2013, ASM Journals

    Dr Makoto Takeda

  77. Canine Distemper Virus Associated with a Lethal Outbreak in Monkeys Can Readily Adapt To Use Human Receptors

    Article • Journal of Virology, April 2013, ASM Journals

    Dr Makoto Takeda, Dr Masayuki Saijo

  78. Simple method for differentiating measles vaccine from wild‐type strains using loop‐mediated isothermal amplification

    Article • Microbiology and Immunology, March 2013, Wiley

    Dr Makoto Takeda

  79. The Receptor-Binding Site of the Measles Virus Hemagglutinin Protein Itself Constitutes a Conserved Neutralizing Epitope

    Article • Journal of Virology, January 2013, ASM Journals

    Dr Makoto Takeda

  80. Sensitive detection of measles virus infection in the blood and tissues of humanized mouse by one-step quantitative RT-PCR

    Article • Frontiers in Microbiology, January 2013, Frontiers

    Dr Makoto Takeda

  81. Canine distemper virus with the intact C protein has the potential to replicate in human epithelial cells by using human nectin4 as a receptor

    Article • Virology, January 2013, Elsevier

    Dr Makoto Takeda

  82. Molecular Evolution of Hemagglutinin (H) Gene in Measles Virus Genotypes D3, D5, D9, and H1

    Article • PLOS One, November 2012, PLOS

    Dr Makoto Takeda, Professor Hirokazu Kimura

  83. Lethal Canine Distemper Virus Outbreak in Cynomolgus Monkeys in Japan in 2008

    Article • Journal of Virology, November 2012, ASM Journals

    Dr Masayuki Saijo, Dr Makoto Takeda

  84. Functional and Structural Characterization of Neutralizing Epitopes of Measles Virus Hemagglutinin Protein

    Article • Journal of Virology, October 2012, ASM Journals

    Dr Makoto Takeda

  85. Triggering the measles virus membrane fusion machinery

    Article • Proceedings of the National Academy of Sciences, October 2012, Proceedings of the National Academy of Sciences

    Dr Makoto Takeda

  86. Nectin4 Is an Epithelial Cell Receptor for Canine Distemper Virus and Involved in Neurovirulence

    Article • Journal of Virology, July 2012, ASM Journals

    Dr Makoto Takeda

  87. HIV-1 Infection Ex Vivo Accelerates Measles Virus Infection by Upregulating Signaling Lymphocytic Activation Molecule (SLAM) in CD4+ T Cells

    Article • Journal of Virology, April 2012, ASM Journals

    Dr Makoto Takeda

  88. Wild-Type Measles Virus is Intrinsically Dual-Tropic

    Article • Frontiers in Microbiology, January 2012, Frontiers

    Dr Makoto Takeda

  89. Morvilliviruses

    Article • Uirusu, January 2012, Japanese Association of Virology

    Dr Makoto Takeda

  90. The SI Strain of Measles Virus Derived from a Patient with Subacute Sclerosing Panencephalitis Possesses Typical Genome Alterations and Unique Amino Acid Changes That Modulate Receptor Specificity and Reduce Membrane Fusion Activity

    Article • Journal of Virology, September 2011, ASM Journals

    Dr Makoto Takeda

  91. Global Distribution of Measles Genotypes and Measles Molecular Epidemiology

    Article • The Journal of Infectious Diseases, July 2011, Oxford University Press (OUP)

    Dr Makoto Takeda

  92. Genetic Characterization of Measles Vaccine Strains

    Article • The Journal of Infectious Diseases, June 2011, Oxford University Press (OUP)

    Dr Makoto Takeda

  93. Elucidation of the full genetic information of Japanese rubella vaccines and the genetic changes associated with in vitro and in vivo vaccine virus phenotypes

    Article • Vaccine, February 2011, Elsevier

    Dr Makoto Takeda

  94. PIASy Inhibits Virus-induced and Interferon-stimulated Transcription through Distinct Mechanisms

    Article • Journal of Biological Chemistry, January 2011, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Makoto Takeda

  95. Two Different Receptors for Wild Type Measles Virus

    Article • Uirusu, January 2011, Japanese Association of Virology

    Dr Makoto Takeda

  96. Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2

    Article • Journal of Virology, October 2010, ASM Journals

    Dr Makoto Takeda

  97. PS2-48 PIASy inhibits virus induced type I interferon production

    Article • Cytokine, October 2010, Elsevier

    Dr Makoto Takeda

  98. Conversion of viable but nonculturable Vibrio cholerae to the culturable state by co-culture with eukaryotic cells

    Article • Microbiology and Immunology, August 2010, Wiley

    Dr Makoto Takeda

  99. The F Gene of the Osaka-2 Strain of Measles Virus Derived from a Case of Subacute Sclerosing Panencephalitis Is a Major Determinant of Neurovirulence

    Article • Journal of Virology, August 2010, ASM Journals

    Dr Makoto Takeda

  100. Corrigendum to “Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma”

    Article • Molecular Therapy, June 2010, Elsevier

    Dr Makoto Takeda

  101. Epithelial-Mesenchymal Transition Abolishes the Susceptibility of Polarized Epithelial Cell Lines to Measles Virus

    Article • Journal of Biological Chemistry, April 2010, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Makoto Takeda

  102. Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma

    Article • Molecular Therapy, March 2010, Elsevier

    Dr Makoto Takeda

  103. The Matrix Protein of Measles Virus Regulates Viral RNA Synthesis and Assembly by Interacting with the Nucleocapsid Protein

    Article • Journal of Virology, January 2010, ASM Journals

    Dr Makoto Takeda

  104. Both RIG-I and MDA5 RNA Helicases Contribute to the Induction of Alpha/Beta Interferon in Measles Virus-Infected Human Cells

    Article • Journal of Virology, October 2009, ASM Journals

    Dr Makoto Takeda

  105. A Highly Attenuated Measles Virus Vaccine Strain Encodes a Fully Functional C Protein

    Article • Journal of Virology, September 2009, ASM Journals

    Dr Makoto Takeda

  106. Mitofusin 2 Inhibits Mitochondrial Antiviral Signaling

    Article • Science Signaling, August 2009, American Association for the Advancement of Science

    Dr Makoto Takeda

  107. The Matrix Protein of Measles Virus Regulates Viral RNA Synthesis and Assembly by Interacting with the Nucleocapsid Protein

    Article • Journal of Virology, August 2009, ASM Journals

    Dr Makoto Takeda

  108. Reduced ability of hemagglutinin of the CAM-70 measles virus vaccine strain to use receptors CD46 and SLAM

    Article • Vaccine, June 2009, Elsevier

    Dr Makoto Takeda

  109. Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin

    Article • Journal of Virology, January 2009, ASM Journals

    Professor Stefan Pöhlmann, Dr Makoto Takeda

  110. Measles Virus Receptors

    Article • January 2009, Springer Science + Business Media

    Dr Makoto Takeda

  111. Measles Viruses Possessing the Polymerase Protein Genes of the Edmonston Vaccine Strain Exhibit Attenuated Gene Expression and Growth in Cultured Cells and SLAM Knock-In Mice

    Article • Journal of Virology, September 2008, ASM Journals

    Dr Makoto Takeda

  112. Measles Virus Circumvents the Host Interferon Response by Different Actions of the C and V Proteins

    Article • Journal of Virology, June 2008, ASM Journals

    Dr Makoto Takeda

  113. Efficient Multiplication of Human Metapneumovirus in Vero Cells Expressing the Transmembrane Serine Protease TMPRSS2

    Article • Journal of Virology, June 2008, ASM Journals

    Dr Makoto Takeda

  114. Measles virus breaks through epithelial cell barriers to achieve transmission

    Article • Journal of Clinical Investigation, June 2008, American Society for Clinical Investigation

    Dr Makoto Takeda

  115. Homogeneous sugar modification improves crystallization of measles virus hemagglutinin

    Article • Journal of Virological Methods, April 2008, Elsevier

    Dr Makoto Takeda

  116. Measles Virus Infects both Polarized Epithelial and Immune Cells by Using Distinctive Receptor-Binding Sites on Its Hemagglutinin

    Article • Journal of Virology, February 2008, ASM Journals

    Dr Makoto Takeda

  117. Role of Lipid Microdomains in Influenza Virus Multiplication

    Article • January 2008, World Scientific Pub Co Pte Lt

    Dr Makoto Takeda

  118. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines

    Article • Proceedings of the National Academy of Sciences, December 2007, Proceedings of the National Academy of Sciences

    Dr Makoto Takeda

  119. A Human Lung Carcinoma Cell Line Supports Efficient Measles Virus Growth and Syncytium Formation via a SLAM- and CD46-Independent Mechanism

    Article • Journal of Virology, August 2007, ASM Journals

    Dr Makoto Takeda

  120. Altered Interaction of the Matrix Protein with the Cytoplasmic Tail of Hemagglutinin Modulates Measles Virus Growth by Affecting Virus Assembly and Cell-Cell Fusion

    Article • Journal of Virology, April 2007, ASM Journals

    Dr Makoto Takeda

  121. Reverse Genetics System for Measles Virus: Establishment and Applications for Analysis of Virus Replication and Pathogenesis

    Article • Uirusu, January 2007, Japanese Association of Virology

    Dr Makoto Takeda

  122. Multiple Amino Acid Substitutions in Hemagglutinin Are Necessary for Wild-Type MeaslesVirus To Acquire the Ability To Use Receptor CD46 Efficiently

    Article • Journal of Virology, December 2006, ASM Journals

    Dr Makoto Takeda

  123. Measles Virus Infection of SLAM (CD150) Knockin Mice Reproduces Tropism and Immunosuppression in Human Infection

    Article • Journal of Virology, November 2006, ASM Journals

    Dr Makoto Takeda

  124. Rescue system for measles virus from cloned cDNA driven by vaccinia virus Lister vaccine strain

    Article • Journal of Virological Methods, October 2006, Elsevier

    Dr Makoto Takeda

  125. Measles virus: cellular receptors, tropism and pathogenesis

    Article • Journal of General Virology, October 2006, Society for General Microbiology

    Dr Makoto Takeda

  126. Translational Inhibition and Increased Interferon Induction in Cells Infected with C Protein-Deficient Measles Virus

    Article • Journal of Virology, September 2006, ASM Journals

    Dr Makoto Takeda

  127. Recombinant wild-type measles virus containing a single N481Y substitution in its haemagglutinin cannot use receptor CD46 as efficiently as that having the haemagglutinin of the Edmonston laboratory strain

    Article • Journal of General Virology, June 2006, Society for General Microbiology

    Dr Makoto Takeda

  128. Generation of Measles Virus with a Segmented RNA Genome

    Article • Journal of Virology, May 2006, ASM Journals

    Dr Makoto Takeda

  129. Contributions of Matrix and Large Protein Genes of the Measles Virus Edmonston Strain to Growth in Cultured Cells as Revealed by Recombinant Viruses

    Article • Journal of Virology, December 2005, ASM Journals

    Dr Makoto Takeda

  130. Long Untranslated Regions of the Measles Virus M and F Genes Control Virus Replication and Cytopathogenicity

    Article • Journal of Virology, November 2005, ASM Journals

    Dr Makoto Takeda

  131. Influenza Virus Hemagglutinin (H3 Subtype) Requires Palmitoylation of Its Cytoplasmic Tail for Assembly: M1 Proteins of Two Subtypes Differ in Their Ability To Support Assembly

    Article • Journal of Virology, November 2005, ASM Journals

    Dr Makoto Takeda

  132. Stringent Requirement for the C Protein of Wild-Type Measles Virus for Growth both In Vitro and in Macaques

    Article • Journal of Virology, June 2005, ASM Journals

    Dr Makoto Takeda

  133. Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells

    Article • Virus Research, March 2005, Elsevier

    Dr Makoto Takeda

  134. Cell tropism of wild-type measles virus is affected by amino acid substitutions in the P, V and M proteins, or by a truncation in the C protein

    Article • Journal of General Virology, October 2004, Society for General Microbiology

    Dr Makoto Takeda

  135. Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction

    Article • Journal of General Virology, October 2004, Society for General Microbiology

    Dr Makoto Takeda

  136. Lipid Raft and Influenza Virus-Viral Glycoproteins on a Raft-

    Article • Uirusu, January 2004, Japanese Association of Virology

    Dr Makoto Takeda

  137. Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains

    Article • Biochemical and Biophysical Research Communications, November 2003, Elsevier

    Dr Makoto Takeda

  138. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion

    Article • Proceedings of the National Academy of Sciences, October 2003, Proceedings of the National Academy of Sciences

    Dr Makoto Takeda

  139. Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism

    Article • Virus Research, July 2003, Elsevier

    Dr Makoto Takeda

  140. Influenza B Virus BM2 Protein Has Ion Channel Activity that Conducts Protons across Membranes

    Article • Developmental Cell, July 2003, Elsevier

    Dr Makoto Takeda

  141. Measles virus V protein blocks interferon (IFN)‐α/β but not IFN‐γ signaling by inhibiting STAT1 and STAT2 phosphorylation

    Article • FEBS Letters, May 2003, Wiley

    Dr Makoto Takeda

  142. Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface

    Article • Virology, February 2003, Elsevier

    Dr Makoto Takeda

  143. SLAM (CD150)-Independent Measles Virus Entry as Revealed by Recombinant Virus Expressing Green Fluorescent Protein

    Article • Journal of Virology, July 2002, ASM Journals

    Dr Makoto Takeda

  144. Recombinant Wild-Type and Edmonston Strain Measles Viruses Bearing Heterologous H Proteins: Role of H Protein in Cell Fusion and Host Cell Specificity

    Article • Journal of Virology, May 2002, ASM Journals

    Dr Makoto Takeda

  145. Influenza A Virus M2 Ion Channel Activity Is Essential for Efficient Replication in Tissue Culture

    Article • Journal of Virology, February 2002, ASM Journals

    Dr Makoto Takeda

  146. Death by influenza virus protein

    Article • Nature Medicine, December 2001, Springer Science + Business Media

    Dr Makoto Takeda

  147. Recovery of Pathogenic Measles Virus from Cloned cDNA

    Article • Journal of Virology, July 2000, ASM Journals

    Dr Makoto Takeda

  148. The Genome Nucleotide Sequence of a Contemporary Wild Strain of Measles Virus and Its Comparison with the Classical Edmonston Strain Genome

    Article • Virology, April 1999, Elsevier

    Dr Makoto Takeda, Dr Takemasa Sakaguchi